Invention Grant
US08383641B2 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
有权
适用于治疗对多巴胺D3受体调节作用的病症的芳氧基乙胺化合物
- Patent Title: Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
- Patent Title (中): 适用于治疗对多巴胺D3受体调节作用的病症的芳氧基乙胺化合物
-
Application No.: US12296739Application Date: 2007-04-13
-
Publication No.: US08383641B2Publication Date: 2013-02-26
- Inventor: Roland Grandel , Wilfried Martin Braje , Andreas Haupt , Sean Colm Turner , Udo Lange , Karla Drescher , Liliane Unger
- Applicant: Roland Grandel , Wilfried Martin Braje , Andreas Haupt , Sean Colm Turner , Udo Lange , Karla Drescher , Liliane Unger
- Applicant Address: DE Wiesbaden
- Assignee: Abbott GmbH & Co. KG
- Current Assignee: Abbott GmbH & Co. KG
- Current Assignee Address: DE Wiesbaden
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Priority: EP06007923 20060414
- International Application: PCT/EP2007/053633 WO 20070413
- International Announcement: WO2007/118859 WO 20071025
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/4965 ; C07D213/62 ; C07D239/34
Abstract:
The present invention relates to aryloxyethylamine compounds of the formula I and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
Public/Granted literature
Information query
